Catalyst should not lower itself to those in the gutter. Catalyst has made amazing progress with Firdapse and even has the highly coveted "Breakthrough Therapy" designation from the FDA that cannot be denied. Firdpase approval is a sure thing and it's right around the corner along with higher prices that will reward the smart investors who are buying today. Just look at the AEGR and ACAD comps and it is easy to see why CPRX prices will be easily in the teens very soon.
Smart investors will use this buying opportunity to load up at bargain basement prices.
bs....management needs to show some balls here and say something. Someone who has a large audience just sh#t on your company and to remain quiet is NOT the correct response. You support your investors by taking a stand